Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tetrahydrocannabinol
Therapeutic Area : Undisclosed
Study Phase : Phase I
Recipient : Par Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions
Details : Dronabinol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Inapplicable
June 27, 2011
Lead Product(s) : Tetrahydrocannabinol
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Recipient : Par Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable